Wealth Science Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Wealth Science Advisors's VRTX Position: Q3 2026 in Review
Wealth Science Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 3.1% in Q3 2026, selling an estimated $43.5K and leaving 2,645 shares worth $1.38M. The position accounts for 0.58% of the portfolio, ranked #25.
Wealth Science Advisors first reported a position in VRTX in Q4 2025 and has held it in 4 quarters since. 1,796 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Wealth Science Advisors held 2,645 shares of Vertex Pharmaceuticals worth $1.38M as of Q3 2026.
- Wealth Science Advisors sold 85 Vertex Pharmaceuticals shares in Q3 2026, an estimated $43.5K.
- Vertex Pharmaceuticals made up 0.58% of Wealth Science Advisors's portfolio in Q3 2026, its #25 holding.
- Wealth Science Advisors first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- 1,796 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Wealth Science Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.